RMD
RESMED INC
-1.52 (-0.67%)226.73USD354K成交股數32.7B市值21.7本益比(近四季)5.8股價營收比+10.8%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.4B+11% | 1.4B+11% | 1.3B+9% | 1.3B+13% | 1.3B+11% | 1.3B+16% | 1.2B+9% | 1.2B+7% | 1.2B | 1.1B | 1.1B | 1.1B |
| 營業成本 | 540M | 544M | 515M | 528M | 525M | 531M | 507M | 504M | 516M | 502M | 505M | 499M |
| 毛利 | 891M+16% | 879M+17% | 821M+14% | 820M+18% | 766M+18% | 751M+25% | 717M+16% | 693M+12% | 647M | 600M | 617M | 618M |
| 毛利率 | 62.2% | 61.8% | 61.5% | 60.8% | 59.3% | 58.6% | 58.6% | 57.9% | 55.6% | 54.4% | 55.0% | 55.3% |
| 研發費用 | 94.3M | 91.0M | 87.3M | 86.4M | 83.9M | 81.4M | 79.5M | 77.1M | 73.9M | 75.7M | 78.1M | 76.4M |
| 銷售管理費用 | 286M | 278M | 259M | 267M | 245M | 242M | 239M | 230M | 222M | 223M | 240M | 228M |
| 營業利益 | 500M+17% | 492M+18% | 447M+15% | 455M+21% | 426M+55% | 417M+44% | 387M+41% | 375M+25% | 275M | 289M | 275M | 301M |
| 營業利益率 | 34.9% | 34.6% | 33.4% | 33.7% | 33.0% | 32.5% | 31.6% | 31.3% | 23.7% | 26.2% | 24.5% | 26.9% |
| 稅後淨利 | 399M+9% | 393M+14% | 349M+12% | 380M+26% | 365M+75% | 345M+57% | 311M+36% | 300M+29% | 209M | 219M | 230M | 233M |
| 淨利率 | 27.9% | 27.6% | 26.1% | 28.2% | 28.3% | 26.9% | 25.4% | 25.1% | 18.0% | 19.9% | 20.5% | 20.8% |
| 稀釋 EPS | 2.74+10% | 2.68+15% | 2.37+12% | 2.58+26% | 2.48+75% | 2.34+57% | 2.11+36% | 2.04+29% | 1.42 | 1.49 | 1.55 | 1.58 |
| 稀釋股數 | 146M | 146M | 147M | 147M | 147M | 147M | 148M | 147M | 148M | 147M | 147M | 147M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.7B | 1.4B | 1.4B | 1.2B | 933M | 522M | 426M | 238M | 210M | 209M | 228M | 228M |
| 應收帳款 | 999M | 986M | 907M | 939M | 908M | 860M | 811M | 779M | 730M | 692M | 705M | 686M |
| 存貨 | 912M | 922M | 946M | 928M | 863M | 882M | 918M | 829M | 933M | 958M | 998M | 1.0B |
| 總資產 | 8.8B | 8.5B | 8.3B | 8.2B | 7.6B | 7.1B | 7.2B | 6.8B | 6.9B | 6.7B | 6.8B | 6.7B |
| 有息負債 | 404M | 404M | 409M | 658M | 663M | 663M | 668M | 997M | 1.2B | 1.4B | 1.4B | 1.6B |
| 總負債 | 2.3B | 2.2B | 2.2B | 2.2B | 2.0B | 1.9B | 2.0B | 2.2B | 2.4B | 2.5B | 2.6B | 2.8B |
| 股東權益 | 6.5B | 6.3B | 6.1B | 6.0B | 5.5B | 5.3B | 5.2B | 4.6B | 4.5B | 4.3B | 4.1B | 3.9B |
| 負債比 | 26.1% | 25.7% | 26.3% | 27.0% | 26.7% | 26.4% | 28.1% | 32.1% | 35.1% | 36.9% | 38.8% | 41.4% |
| 淨現金(現金 − 有息負債) | 1.3B | 1.0B | 975M | 551M | 270M | −141M | −241M | −759M | −1.0B | −1.1B | −1.2B | −1.3B |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 457M+40% | – | – | – | 326M | – | – | 286M | – | – |
| 資本支出 | – | – | 43.0M | – | – | – | 17.8M | – | – | 30.0M | – | – |
| 自由現金流 | – | – | 414M+35% | – | – | – | 308M | – | – | 256M | – | – |
| 折舊攤銷 | 59.0M | 49.9M | 47.7M | 63.6M | 43.7M | 46.4M | 44.7M | 43.5M | 44.8M | 44.9M | 46.8M | 44.4M |
| 買回庫藏股 | – | – | 150M | – | – | – | 50.0M | – | – | 0.00 | – | – |
| 現金股利 | – | – | 87.8M | – | – | – | 77.9M | – | – | 70.6M | – | – |
| 自由現金流率 | – | – | 31.0% | – | – | – | 25.1% | – | – | 23.2% | – | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 5.7B
| Sleep And Breathing Health | 5.0B | 88.0% | +10.5% |
|---|---|---|---|
| Residential Care Software | 676M | 12.0% | +5.4% |
地區2026 年度 · 5.7B
| 美國 | 3.6B | 63.0% | +8.4% |
|---|---|---|---|
| 美國以外 | 2.1B | 37.0% | +12.4% |
產品／服務2026 年度 · 5.7B
| Sleep And Breathing Health | 5.0B | 88.0% | +10.5% |
|---|---|---|---|
| Residential Care Software | 676M | 12.0% | +5.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 5.7B | +9.9% | 1.5B | 26.9% | 10.43 | 1.6B |
| FY2025 | 5.1B | +9.8% | 1.4B | 27.2% | 9.51 | 1.7B |
| FY2024 | 4.7B | +10.9% | 1.0B | 21.8% | 6.92 | 1.3B |
| FY2023 | 4.2B | +18.0% | 898M | 21.3% | 6.09 | 574M |
| FY2022 | 3.6B | +11.9% | 779M | 21.8% | 5.30 | 216M |
| FY2021 | 3.2B | +8.1% | 475M | 14.8% | 3.24 | 634M |
| FY2020 | 3.0B | +13.4% | 622M | 21.0% | 4.27 | 707M |
| FY2019 | 2.6B | – | 405M | 15.5% | 2.80 | 390M |